v3.26.1
Note 11 - Income Tax Provision
 12 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

Note 11 — Income Tax Provision

 

The Company’s income tax provision can be affected by many factors, including the overall level of pre-tax income, the mix of pre-tax income generated across the various jurisdictions in which the Company operates, changes in tax laws and regulations in those jurisdictions, changes in valuation allowances on its deferred tax assets, tax planning strategies available to the Company, and other discrete items.

 

The components of pretax loss and income tax (benefit) expense are as follows (in thousands):

 

  

Year Ended March 31,

 
  

2026

  

2025

 

Loss before income taxes:

        

Domestic

 $(2,644) $(6,434)

Foreign

  -   - 

Total loss before income taxes

 $(2,644) $(6,434)

The provision for income taxes consisted of the following:

        

Current

        

U.S. Federal

 $-  $- 

State

  17   24 

Foreign

  -   - 

Total Current

  17   24 
         

Deferred:

        

U.S. Federal

  (209)  (899)

State

  (851)  (163)

Foreign

  -   - 

Total Deferred

  (1,060)  (1,062)

Valuation allowance

  1,043   1,062 

Total provision for income taxes

 $-  $24 

 

The differences between income taxes expected at U.S. statutory income tax rates and the income tax provision are as follows (dollars in thousands):

 

  

Year Ended March 31, 2026

 
         

Income taxes computed at Federal statutory rate

 $(555)  21.00%

State and local income taxes, net of federal income tax effect (a)

  179   (6.78)%

Valuation allowance

  209   (7.92)%

Other

  167   (6.30)%

Total provision for taxes

 $-   0.00%

(a) State taxes in California make up the majority of the tax effect in this category

        
         

 

  

Year Ended

 
  

March 31, 2025

 
     

Income taxes computed at Federal statutory rate

 $(1,291)

State tax — net of federal benefit

  (174)

Federal NOL true-up

  31 

Change in valuation allowance

  1,063 

Stock compensation

  181 

Other

  214 

Total provision for income taxes

 $24 

 

At March 31, 2026, the Company had available federal and state net operating loss carryforwards to reduce future taxable income of approximately $14.1 million and $23.1 million, respectively. The federal and state net operating loss carryforwards begin to expire on various dates beginning in 2034. Of the $14.1 million of federal net operating loss carryforwards, $3.5 million was generated in tax years beginning before March 31, 2018 and is subject to the 20-year carryforward period, the remaining $10.6 million can be carried forward indefinitely but is subject to the 80% taxable income limitation.

 

The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by the federal and state jurisdictions where applicable. There are currently no pending income tax examinations. The Company’s tax years for 2018 and forward are subject to examination by the federal tax authorities and tax years for 2015 and forward are subject to examination by California tax authorities due to the carryforward of unutilized net operating losses.

 

The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of March 31, 2026 and 2025, the Company has not accrued interest or penalties related to uncertain tax positions.

 

Significant components of the Company’s deferred income tax assets and (liabilities) are as follows as of (in thousands):

 

  

Year Ended March 31,

 
  

2026

  

2025

 

Deferred tax assets:

        

Net operating loss carryforwards

 $4,579  $3,732 

Reserves and allowances

  71   20 

Accrued liabilities

  176   151 

Charitable contribution carryforward

  1,083   946 

Gross deferred tax assets

  5,909   4,849 

Valuation allowance

  (5,909)  (4,849)

Net deferred tax liability

 $-  $- 

 

As the ultimate realization of the potential benefits of a portion of the Company’s deferred tax assets is considered unlikely by management, the Company has offset the deferred tax assets attributable to those potential benefits through valuation allowances. Accordingly, the Company did not recognize any benefit from income taxes in the accompanying consolidated statements of operations to offset its pre-tax losses. The valuation allowance against deferred tax assets is $5.9 million and $4.8 million for the years ended March 31, 2026 and 2025, respectively. The valuation allowance increased by $1.1 million for the year ended March 31, 2026.